A pharmacotherapy of atrial fibrillation in subclinical thyrotoxicosis
Background. Pharmacological therapy of atrial fibrillation (AF) in subclinical dysfunction of the thyroid – is the most important problem of modern clinical medicine. The purpose of the study is to conduct a complex assessment of electrophysiological indicators of the heart and lipid profile in p...
Main Authors: | R.F. Rakhmatullov, L.V. Mel'nikova, I.Ya. Moiseeva, F.K. Rakhmatullov |
---|---|
Format: | Article |
Language: | English |
Published: |
Penza State University Publishing House
2021-09-01
|
Series: | Известия высших учебных заведений. Поволжский регион: Медицинские науки |
Subjects: |
Similar Items
-
The State and Interactions of the System of Cytokines in Autoimmune Thyrotoxicosis
Published: (2013-12-01) -
Comparative Analysis of Espa-Carb Efficacy in Patients with Hyperthyroidism
by: V.I. Pankiv
Published: (2014-05-01) -
Determinants of development and preservation of atrial fibrillation at thyrotoxicosis
Published: (2013-03-01) -
Stroke in a Young Man Secondary to Paroxysmal Atrial Fibrillation and Thyrotoxicosis: A Case Report
by: Rodrigo Bazan, et al.
Published: (2017-10-01) -
Assessment of the effect of -blockers on the functional state in patients with ventricular arrhythmias: results of a comparative study
by: Iosif Z. Shubitidze, et al.
Published: (2020-09-01)